Inhibition of p38 enhances ERK inhibitor efficacy in pancreatic ductal adenocarcinoma

被引：0
|
作者：
Ryan, Meagan B.
Bryant, Kirsten L.
Hayes, Tikvah K.
Kher, Swapnil
Wood, Kris C.
Samatar, Ahmed A.
Cox, Adrienne D.
Der, Channing J.
机构：
来源：
CANCER RESEARCH | 2016年 / 76卷
关键词：
D O I：
10.1158/1538-7445.AM2016-4660
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4660
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Dynamic distribution of ERK, p38 and JNK during the development of pancreatic ductal adenocarcinoma
    Amsterdam, Abraham
    Shpigner, Lotem
    Raanan, Calanit
    Schreiber, Letizia
    Melzer, Ehud
    Seger, Rony
    ACTA HISTOCHEMICA, 2014, 116 (08) : 1434 - 1442
  • [2] EREG silencing inhibits tumorigenesis via inactivating ERK/p38 MAPK pathway in pancreatic ductal adenocarcinoma
    Liu, Fuyuan
    Wu, Weikang
    Cao, Weiwei
    Feng, Liangyong
    Yuan, Juzheng
    Ren, Zhuohui
    Dai, Niu
    Wang, Xudan
    Li, Xiao
    Yue, Shuqiang
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2024, 1870 (07):
  • [3] Tumor Priming by SMO Inhibition Enhances Antibody Delivery and Efficacy in a Pancreatic Ductal Adenocarcinoma Model
    Wang, Jun
    Chan, Darren K. W.
    Sen, Arindam
    Ma, Wen Wee
    Straubinger, Robert M.
    MOLECULAR CANCER THERAPEUTICS, 2019, 18 (11) : 2074 - 2084
  • [4] Improving the efficacy of dual ERK-MAPK and autophagy inhibition as a therapeutic strategy for pancreatic ductal adenocarcinoma
    DeLiberty, Jonathan M.
    Stalnecker, Clint A.
    Drizyte-Miller, Kristina
    Schechter, Elyse G.
    Pieper, Noah L.
    Yang, Runying
    Der, Channing J.
    Cox, Adrienne D.
    Bryant, Kirsten L.
    CANCER RESEARCH, 2023, 83 (07)
  • [5] Improving the efficacy of dual ERK-MAPK and autophagy inhibition as a therapeutic strategy for pancreatic ductal adenocarcinoma
    DeLiberty, Jonathan M.
    Roach, Mallory K.
    Pieper, Noah L.
    Drizyte-Miller, Kristina
    Schechter, Elyse G.
    Yang, Runying
    Der, Channing J.
    Cox, Adrienne D.
    Stalnecker, Clint A.
    Bryant, Kirsten L.
    CANCER RESEARCH, 2024, 84 (02)
  • [6] Oxidative stress induces monocyte-to-myofibroblast transdifferentiation through p38 in pancreatic ductal adenocarcinoma
    Huang, Xin
    He, Chaobin
    Hua, Xin
    Kan, Anna
    Mao, Yize
    Sun, Shuxin
    Duan, Fangting
    Wang, Jun
    Huang, Peng
    Li, Shengping
    CLINICAL AND TRANSLATIONAL MEDICINE, 2020, 10 (02):
  • [7] p38 inhibitor enhances growth inhibition and death in gallic acid-treated endothelial cells
    Yang, Yeon Mi
    Park, Woo Hyun
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2010, 26 (02) : 295 - 300
  • [8] Inhibition of p38 MAPK in the brain through nasal administration of p38 inhibitor loaded in chitosan nanocapsules
    Casadome-Perales, Alvaro
    De Matteis, Laura
    Alleva, Maria
    Infantes-Rodriguez, Cristina
    Palomares-Perez, Irene
    Saito, Takashi
    Saido, Takaomi C.
    Esteban, Jose A.
    Nebreda, Angel R.
    de la Fuente, Jesus M.
    Dotti, Carlos G.
    NANOMEDICINE, 2019, 14 (18) : 2409 - 2422
  • [9] Inhibition of Bromodomain Proteins Enhances Oncolytic HAdVC5 Replication and Efficacy in Pancreatic Ductal Adenocarcinoma (PDAC) Models
    Miao, Tizong
    Symonds, Alistair
    Hickman, Oliver J.
    Wu, Dongsheng
    Wang, Ping
    Lemoine, Nick
    Wang, Yaohe
    Linardopoulos, Spiros
    Hallden, Gunnel
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (02)
  • [10] Inhibition of p38 MAP kinase activity enhances axonal regeneration
    Myers, RR
    Sekiguchi, Y
    Kikuchi, S
    Scott, B
    Medicherla, S
    Protter, A
    Campana, WM
    EXPERIMENTAL NEUROLOGY, 2003, 184 (02) : 606 - 614
12345